NYSE American - Delayed Quote ? USD Myomo, Inc. (MYO) Follow Compare 3.7600 -0.0100 (-0.27%) At close: October 25 at 4:00 PM EDT 3.7400 -0.02 (-0.53%) After hours: October 25 at 7:51 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... Myomo Inc (MYO) reports a 77% revenue surge and outlines plans for increased manufacturing capacity and market expansion. GuruFocus.com ? 16 days ago MYO -0.27% Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit BOSTON, October 09, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will participate in a "Fireside Chat" at the 2024 Maxim Healthcare Virtual Summit. The virtual summit is being presented by Maxim Group LLC, from Octob Business Wire ? 16 days ago MYO -0.27% Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly BOSTON, September 12, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. Business Wire ? last month MYO -0.27% Myomo to Participate in Two Investor Conferences in September BOSTON, September 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be participating in two investor conferences during the month of September. Business Wire ? last month MYO -0.27% Myomo Reports Second Quarter 2024 Financial Results BOSTON, August 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2024. Business Wire ? 2 months ago MYO -0.27% Myomo to Report Second Quarter Financial Results on August 6, 2024 BOSTON, July 30, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2024 on August 6, 2024. Business Wire ? 2 months ago MYO -0.27% The 3 Best Robotic Exoskeleton Stocks to Buy Now An exciting, under-the-radar development is unfolding. I’m referring to the development of Robotic Exoskeletons, a phenomenon that could literally be life-changing to some. This has also opened the door to the best Robotic Exoskeleton stocks. For those unaware, Robotic Exoskeletons attach to the human body to aid mechanical movement. Among other reasons, the concept was designed to provide paralyzed individuals with a more convenient life. Although in its early stages, exoskeleton development ha InvestorPlace ? 2 months ago EKSO +1.96% MYO -0.27% Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now We recently compiled a list of the 8 Best Robotics Stocks Under $10. In this article, we are going to take a look at where Myomo, Inc. (NYSE:MYO) stands against the other robotic stocks under $10. The concept of lifelike machines performing human tasks is fascinating to some and unsettling to others. However, robotics is […] Insider Monkey ? 2 months ago MYO -0.27% Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics BOSTON, July 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, reports preliminary revenues and operating metrics for the three months ended June 30, 2024. Business Wire ? 3 months ago MYO -0.27% Sidoti Events, LLC's Virtual June Small-Cap Conference NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. ... ACCESSWIRE ? 4 months ago MYRG TBPH TWI Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 BOSTON, June 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024. Business Wire ? 4 months ago MYO -0.27% Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) On May 29, 2024, Thomas Kirk, Director at Myomo Inc (MYO), purchased 50,000 shares of the company, as reported in the SEC Filing. GuruFocus.com ? 4 months ago MYO -0.27% Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) On May 15, 2024, Harry Kovelman, Chief Medical Officer of Myomo Inc (MYO), executed a sale of 35,426 shares of the company. GuruFocus.com ? 5 months ago MYO -0.27% MYO: Myomo is Driving Advancements in Wearable Technology NYSE:MYO Myomo, Inc. (NYSE:MYO) specializes in wearable medical robotics, focusing on improving arm and hand function for people with neurological disorders or upper-limb paralysis. The company developed and commercialized the MyoPro product line, powered upper-limb orthoses designed to support and restore function to weakened or paralyzed arms. MyoPro devices are used by patients with conditions Zacks Small Cap Research ? 5 months ago MYO -0.27% Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges Aligns with EPS Projections, Misses Revenue Estimates GuruFocus.com ? 5 months ago MYO -0.27% Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... Despite a widened net loss, Myomo Inc reports a significant increase in revenue and backlog, setting a positive trajectory for future performance. GuruFocus.com ? 5 months ago MYO -0.27% Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript May 8, 2024 Myomo, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Myomo First Quarter 2024 Earnings Conference Call. All participants are in listen-only mode. […] Insider Monkey ? 5 months ago MYO -0.27% Myomo Reports First Quarter 2024 Financial Results BOSTON, May 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024. Business Wire ? 5 months ago MYO -0.27% Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees BOSTON, May 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services ("CMS"), through their regional contractors known as the DME MACs, have remitted and paid lump sum reimbursements to the Company and are beginning to reimburse orthotics and prosthetics ("O&P") providers f Business Wire ? 5 months ago MYO -0.27% Myomo to Report First Quarter Financial Results on May 8, 2024 BOSTON, May 01, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2024 on May 8, 2024. Business Wire ? 5 months ago MYO -0.27% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return MYO S&P 500 YTD -24.95% +21.77% 1-Year +235.71% +36.74% 3-Year -64.05% +27.79%
